Free Trial
LON:MGCI

M&G Credit Income Investment 3/28/2025 Earnings Report

M&G Credit Income Investment logo
GBX 89.80 0.00 (0.00%)
As of 11:52 AM Eastern

M&G Credit Income Investment EPS Results

Actual EPS
GBX 7.46
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

M&G Credit Income Investment Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

M&G Credit Income Investment Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

M&G Credit Income Investment Earnings Headlines

Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide. On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.tc pixel
See More M&G Credit Income Investment Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like M&G Credit Income Investment? Sign up for Earnings360's daily newsletter to receive timely earnings updates on M&G Credit Income Investment and other key companies, straight to your email.

About M&G Credit Income Investment

M&G Credit Income Investment (LON:MGCI) Trust plc invests in a portfolio of public and private debt and debt-like instruments. The company was incorporated in 2018 and is based in London, the United Kingdom.

View M&G Credit Income Investment Profile